Loading…

Survival and dementia in GBA ‐associated Parkinson's disease: T he mutation matters

Objective The objective of this work was to investigate survival, dementia, and genotype‐phenotype correlations in patients with Parkinson's disease (PD) with and without mutations on the glucocerebrosidase gene ( GBA ). Methods We included 2,764 unrelated consecutive PD patients: 123 GBA carri...

Full description

Saved in:
Bibliographic Details
Published in:Annals of neurology 2016-11, Vol.80 (5), p.662-673
Main Authors: Cilia, Roberto, Tunesi, Sara, Marotta, Giorgio, Cereda, Emanuele, Siri, Chiara, Tesei, Silvana, Zecchinelli, Anna L., Canesi, Margherita, Mariani, Claudio B., Meucci, Nicoletta, Sacilotto, Giorgio, Zini, Michela, Barichella, Michela, Magnani, Corrado, Duga, Stefano, Asselta, Rosanna, Soldà, Giulia, Seresini, Agostino, Seia, Manuela, Pezzoli, Gianni, Goldwurm, Stefano
Format: Article
Language:English
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c747-a552b68a70b46a8ff43a70fb30ce4aec0ab96769cae14c4a3158363ad982beec3
cites cdi_FETCH-LOGICAL-c747-a552b68a70b46a8ff43a70fb30ce4aec0ab96769cae14c4a3158363ad982beec3
container_end_page 673
container_issue 5
container_start_page 662
container_title Annals of neurology
container_volume 80
creator Cilia, Roberto
Tunesi, Sara
Marotta, Giorgio
Cereda, Emanuele
Siri, Chiara
Tesei, Silvana
Zecchinelli, Anna L.
Canesi, Margherita
Mariani, Claudio B.
Meucci, Nicoletta
Sacilotto, Giorgio
Zini, Michela
Barichella, Michela
Magnani, Corrado
Duga, Stefano
Asselta, Rosanna
Soldà, Giulia
Seresini, Agostino
Seia, Manuela
Pezzoli, Gianni
Goldwurm, Stefano
description Objective The objective of this work was to investigate survival, dementia, and genotype‐phenotype correlations in patients with Parkinson's disease (PD) with and without mutations on the glucocerebrosidase gene ( GBA ). Methods We included 2,764 unrelated consecutive PD patients: 123 GBA carriers (67 mild‐p.N370S and 56 severe mainly p.L444P) and 2,641 noncarriers. Brain perfusion and dopamine transporter imaging was analyzed, including dementia with Lewy Bodies (DLB) as an additional control group. Results Multivariable analysis adjusted by sex, age at onset, and disease duration attributed to GBA carriers a greater risk for dementia (hazard ratio [HR] = 3.16; p  
doi_str_mv 10.1002/ana.24777
format article
fullrecord <record><control><sourceid>crossref</sourceid><recordid>TN_cdi_crossref_primary_10_1002_ana_24777</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_1002_ana_24777</sourcerecordid><originalsourceid>FETCH-LOGICAL-c747-a552b68a70b46a8ff43a70fb30ce4aec0ab96769cae14c4a3158363ad982beec3</originalsourceid><addsrcrecordid>eNot0L1OwzAUhmELgUQpDNyBN8SQchw7dsJWKihIlUAizNGJcyIMjYNstxIbl8A1ciWUn-l7p294GDsVMBMA-QV6nOXKGLPHJqKQIitzVe2zCUitskJIdciOYnwBgEoLmLCnx03Yui2uOfqOdzSQTw6583x5NedfH58Y42gdJur4A4ZX5-PozyLvXCSMdMlr_kx82CRMbvR8wJQoxGN20OM60sn_Tll9c10vbrPV_fJuMV9l1iiTYVHkrS7RQKs0ln2v5K77VoIlhWQB20obXVkkoaxCKYpSaoldVeYtkZVTdv53a8MYY6C-eQtuwPDeCGh-OJodR_PLIb8BNWxUQQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Survival and dementia in GBA ‐associated Parkinson's disease: T he mutation matters</title><source>Wiley</source><creator>Cilia, Roberto ; Tunesi, Sara ; Marotta, Giorgio ; Cereda, Emanuele ; Siri, Chiara ; Tesei, Silvana ; Zecchinelli, Anna L. ; Canesi, Margherita ; Mariani, Claudio B. ; Meucci, Nicoletta ; Sacilotto, Giorgio ; Zini, Michela ; Barichella, Michela ; Magnani, Corrado ; Duga, Stefano ; Asselta, Rosanna ; Soldà, Giulia ; Seresini, Agostino ; Seia, Manuela ; Pezzoli, Gianni ; Goldwurm, Stefano</creator><creatorcontrib>Cilia, Roberto ; Tunesi, Sara ; Marotta, Giorgio ; Cereda, Emanuele ; Siri, Chiara ; Tesei, Silvana ; Zecchinelli, Anna L. ; Canesi, Margherita ; Mariani, Claudio B. ; Meucci, Nicoletta ; Sacilotto, Giorgio ; Zini, Michela ; Barichella, Michela ; Magnani, Corrado ; Duga, Stefano ; Asselta, Rosanna ; Soldà, Giulia ; Seresini, Agostino ; Seia, Manuela ; Pezzoli, Gianni ; Goldwurm, Stefano</creatorcontrib><description>Objective The objective of this work was to investigate survival, dementia, and genotype‐phenotype correlations in patients with Parkinson's disease (PD) with and without mutations on the glucocerebrosidase gene ( GBA ). Methods We included 2,764 unrelated consecutive PD patients: 123 GBA carriers (67 mild‐p.N370S and 56 severe mainly p.L444P) and 2,641 noncarriers. Brain perfusion and dopamine transporter imaging was analyzed, including dementia with Lewy Bodies (DLB) as an additional control group. Results Multivariable analysis adjusted by sex, age at onset, and disease duration attributed to GBA carriers a greater risk for dementia (hazard ratio [HR] = 3.16; p  &lt; 0.001) and death (HR = 1.85; p  = 0.002) than noncarriers. When dementia was introduced in the model as a time‐dependent covariate, the mortality risk remained greater in carriers (HR = 1.65; p  = 0.016), suggesting that other clinical features are likely to contribute to reduced survival. At last examination, GBA carriers had worse motor symptoms, particularly nondopaminergic features. Carriers of severe mutations had greater risk for dementia compared to mild mutations ( p  &lt; 0.001), but similar mortality risk. Consistent with clinical data, GBA carriers showed reduced posterior parietal and occipital cortical synaptic activity and nigrostriatal function than PD noncarriers. Neuroimaging features of carriers of mild mutations overlapped with PD noncarriers, whereas carriers of severe mutations were closer to DLB. Interpretation Survival is reduced in GBA carriers compared to noncarriers; this seems to be partially independent from the increased risk for early dementia. The risk for dementia is strongly modulated by type of mutation. In the clinical continuum between PD and DLB, patients with GBA mutations seem to localize midway, with carriers of severe mutations closer to DLB than to idiopathic PD. Ann Neurol 2016;80:662–673</description><identifier>ISSN: 0364-5134</identifier><identifier>EISSN: 1531-8249</identifier><identifier>DOI: 10.1002/ana.24777</identifier><language>eng</language><ispartof>Annals of neurology, 2016-11, Vol.80 (5), p.662-673</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c747-a552b68a70b46a8ff43a70fb30ce4aec0ab96769cae14c4a3158363ad982beec3</citedby><cites>FETCH-LOGICAL-c747-a552b68a70b46a8ff43a70fb30ce4aec0ab96769cae14c4a3158363ad982beec3</cites><orcidid>0000-0002-1651-567X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,786,790,27957,27958</link.rule.ids></links><search><creatorcontrib>Cilia, Roberto</creatorcontrib><creatorcontrib>Tunesi, Sara</creatorcontrib><creatorcontrib>Marotta, Giorgio</creatorcontrib><creatorcontrib>Cereda, Emanuele</creatorcontrib><creatorcontrib>Siri, Chiara</creatorcontrib><creatorcontrib>Tesei, Silvana</creatorcontrib><creatorcontrib>Zecchinelli, Anna L.</creatorcontrib><creatorcontrib>Canesi, Margherita</creatorcontrib><creatorcontrib>Mariani, Claudio B.</creatorcontrib><creatorcontrib>Meucci, Nicoletta</creatorcontrib><creatorcontrib>Sacilotto, Giorgio</creatorcontrib><creatorcontrib>Zini, Michela</creatorcontrib><creatorcontrib>Barichella, Michela</creatorcontrib><creatorcontrib>Magnani, Corrado</creatorcontrib><creatorcontrib>Duga, Stefano</creatorcontrib><creatorcontrib>Asselta, Rosanna</creatorcontrib><creatorcontrib>Soldà, Giulia</creatorcontrib><creatorcontrib>Seresini, Agostino</creatorcontrib><creatorcontrib>Seia, Manuela</creatorcontrib><creatorcontrib>Pezzoli, Gianni</creatorcontrib><creatorcontrib>Goldwurm, Stefano</creatorcontrib><title>Survival and dementia in GBA ‐associated Parkinson's disease: T he mutation matters</title><title>Annals of neurology</title><description>Objective The objective of this work was to investigate survival, dementia, and genotype‐phenotype correlations in patients with Parkinson's disease (PD) with and without mutations on the glucocerebrosidase gene ( GBA ). Methods We included 2,764 unrelated consecutive PD patients: 123 GBA carriers (67 mild‐p.N370S and 56 severe mainly p.L444P) and 2,641 noncarriers. Brain perfusion and dopamine transporter imaging was analyzed, including dementia with Lewy Bodies (DLB) as an additional control group. Results Multivariable analysis adjusted by sex, age at onset, and disease duration attributed to GBA carriers a greater risk for dementia (hazard ratio [HR] = 3.16; p  &lt; 0.001) and death (HR = 1.85; p  = 0.002) than noncarriers. When dementia was introduced in the model as a time‐dependent covariate, the mortality risk remained greater in carriers (HR = 1.65; p  = 0.016), suggesting that other clinical features are likely to contribute to reduced survival. At last examination, GBA carriers had worse motor symptoms, particularly nondopaminergic features. Carriers of severe mutations had greater risk for dementia compared to mild mutations ( p  &lt; 0.001), but similar mortality risk. Consistent with clinical data, GBA carriers showed reduced posterior parietal and occipital cortical synaptic activity and nigrostriatal function than PD noncarriers. Neuroimaging features of carriers of mild mutations overlapped with PD noncarriers, whereas carriers of severe mutations were closer to DLB. Interpretation Survival is reduced in GBA carriers compared to noncarriers; this seems to be partially independent from the increased risk for early dementia. The risk for dementia is strongly modulated by type of mutation. In the clinical continuum between PD and DLB, patients with GBA mutations seem to localize midway, with carriers of severe mutations closer to DLB than to idiopathic PD. Ann Neurol 2016;80:662–673</description><issn>0364-5134</issn><issn>1531-8249</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><recordid>eNot0L1OwzAUhmELgUQpDNyBN8SQchw7dsJWKihIlUAizNGJcyIMjYNstxIbl8A1ciWUn-l7p294GDsVMBMA-QV6nOXKGLPHJqKQIitzVe2zCUitskJIdciOYnwBgEoLmLCnx03Yui2uOfqOdzSQTw6583x5NedfH58Y42gdJur4A4ZX5-PozyLvXCSMdMlr_kx82CRMbvR8wJQoxGN20OM60sn_Tll9c10vbrPV_fJuMV9l1iiTYVHkrS7RQKs0ln2v5K77VoIlhWQB20obXVkkoaxCKYpSaoldVeYtkZVTdv53a8MYY6C-eQtuwPDeCGh-OJodR_PLIb8BNWxUQQ</recordid><startdate>201611</startdate><enddate>201611</enddate><creator>Cilia, Roberto</creator><creator>Tunesi, Sara</creator><creator>Marotta, Giorgio</creator><creator>Cereda, Emanuele</creator><creator>Siri, Chiara</creator><creator>Tesei, Silvana</creator><creator>Zecchinelli, Anna L.</creator><creator>Canesi, Margherita</creator><creator>Mariani, Claudio B.</creator><creator>Meucci, Nicoletta</creator><creator>Sacilotto, Giorgio</creator><creator>Zini, Michela</creator><creator>Barichella, Michela</creator><creator>Magnani, Corrado</creator><creator>Duga, Stefano</creator><creator>Asselta, Rosanna</creator><creator>Soldà, Giulia</creator><creator>Seresini, Agostino</creator><creator>Seia, Manuela</creator><creator>Pezzoli, Gianni</creator><creator>Goldwurm, Stefano</creator><scope>AAYXX</scope><scope>CITATION</scope><orcidid>https://orcid.org/0000-0002-1651-567X</orcidid></search><sort><creationdate>201611</creationdate><title>Survival and dementia in GBA ‐associated Parkinson's disease: T he mutation matters</title><author>Cilia, Roberto ; Tunesi, Sara ; Marotta, Giorgio ; Cereda, Emanuele ; Siri, Chiara ; Tesei, Silvana ; Zecchinelli, Anna L. ; Canesi, Margherita ; Mariani, Claudio B. ; Meucci, Nicoletta ; Sacilotto, Giorgio ; Zini, Michela ; Barichella, Michela ; Magnani, Corrado ; Duga, Stefano ; Asselta, Rosanna ; Soldà, Giulia ; Seresini, Agostino ; Seia, Manuela ; Pezzoli, Gianni ; Goldwurm, Stefano</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c747-a552b68a70b46a8ff43a70fb30ce4aec0ab96769cae14c4a3158363ad982beec3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Cilia, Roberto</creatorcontrib><creatorcontrib>Tunesi, Sara</creatorcontrib><creatorcontrib>Marotta, Giorgio</creatorcontrib><creatorcontrib>Cereda, Emanuele</creatorcontrib><creatorcontrib>Siri, Chiara</creatorcontrib><creatorcontrib>Tesei, Silvana</creatorcontrib><creatorcontrib>Zecchinelli, Anna L.</creatorcontrib><creatorcontrib>Canesi, Margherita</creatorcontrib><creatorcontrib>Mariani, Claudio B.</creatorcontrib><creatorcontrib>Meucci, Nicoletta</creatorcontrib><creatorcontrib>Sacilotto, Giorgio</creatorcontrib><creatorcontrib>Zini, Michela</creatorcontrib><creatorcontrib>Barichella, Michela</creatorcontrib><creatorcontrib>Magnani, Corrado</creatorcontrib><creatorcontrib>Duga, Stefano</creatorcontrib><creatorcontrib>Asselta, Rosanna</creatorcontrib><creatorcontrib>Soldà, Giulia</creatorcontrib><creatorcontrib>Seresini, Agostino</creatorcontrib><creatorcontrib>Seia, Manuela</creatorcontrib><creatorcontrib>Pezzoli, Gianni</creatorcontrib><creatorcontrib>Goldwurm, Stefano</creatorcontrib><collection>CrossRef</collection><jtitle>Annals of neurology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Cilia, Roberto</au><au>Tunesi, Sara</au><au>Marotta, Giorgio</au><au>Cereda, Emanuele</au><au>Siri, Chiara</au><au>Tesei, Silvana</au><au>Zecchinelli, Anna L.</au><au>Canesi, Margherita</au><au>Mariani, Claudio B.</au><au>Meucci, Nicoletta</au><au>Sacilotto, Giorgio</au><au>Zini, Michela</au><au>Barichella, Michela</au><au>Magnani, Corrado</au><au>Duga, Stefano</au><au>Asselta, Rosanna</au><au>Soldà, Giulia</au><au>Seresini, Agostino</au><au>Seia, Manuela</au><au>Pezzoli, Gianni</au><au>Goldwurm, Stefano</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Survival and dementia in GBA ‐associated Parkinson's disease: T he mutation matters</atitle><jtitle>Annals of neurology</jtitle><date>2016-11</date><risdate>2016</risdate><volume>80</volume><issue>5</issue><spage>662</spage><epage>673</epage><pages>662-673</pages><issn>0364-5134</issn><eissn>1531-8249</eissn><abstract>Objective The objective of this work was to investigate survival, dementia, and genotype‐phenotype correlations in patients with Parkinson's disease (PD) with and without mutations on the glucocerebrosidase gene ( GBA ). Methods We included 2,764 unrelated consecutive PD patients: 123 GBA carriers (67 mild‐p.N370S and 56 severe mainly p.L444P) and 2,641 noncarriers. Brain perfusion and dopamine transporter imaging was analyzed, including dementia with Lewy Bodies (DLB) as an additional control group. Results Multivariable analysis adjusted by sex, age at onset, and disease duration attributed to GBA carriers a greater risk for dementia (hazard ratio [HR] = 3.16; p  &lt; 0.001) and death (HR = 1.85; p  = 0.002) than noncarriers. When dementia was introduced in the model as a time‐dependent covariate, the mortality risk remained greater in carriers (HR = 1.65; p  = 0.016), suggesting that other clinical features are likely to contribute to reduced survival. At last examination, GBA carriers had worse motor symptoms, particularly nondopaminergic features. Carriers of severe mutations had greater risk for dementia compared to mild mutations ( p  &lt; 0.001), but similar mortality risk. Consistent with clinical data, GBA carriers showed reduced posterior parietal and occipital cortical synaptic activity and nigrostriatal function than PD noncarriers. Neuroimaging features of carriers of mild mutations overlapped with PD noncarriers, whereas carriers of severe mutations were closer to DLB. Interpretation Survival is reduced in GBA carriers compared to noncarriers; this seems to be partially independent from the increased risk for early dementia. The risk for dementia is strongly modulated by type of mutation. In the clinical continuum between PD and DLB, patients with GBA mutations seem to localize midway, with carriers of severe mutations closer to DLB than to idiopathic PD. Ann Neurol 2016;80:662–673</abstract><doi>10.1002/ana.24777</doi><tpages>12</tpages><orcidid>https://orcid.org/0000-0002-1651-567X</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0364-5134
ispartof Annals of neurology, 2016-11, Vol.80 (5), p.662-673
issn 0364-5134
1531-8249
language eng
recordid cdi_crossref_primary_10_1002_ana_24777
source Wiley
title Survival and dementia in GBA ‐associated Parkinson's disease: T he mutation matters
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-09-22T04%3A36%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-crossref&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Survival%20and%20dementia%20in%20GBA%20%E2%80%90associated%20Parkinson's%20disease:%20T%20he%20mutation%20matters&rft.jtitle=Annals%20of%20neurology&rft.au=Cilia,%20Roberto&rft.date=2016-11&rft.volume=80&rft.issue=5&rft.spage=662&rft.epage=673&rft.pages=662-673&rft.issn=0364-5134&rft.eissn=1531-8249&rft_id=info:doi/10.1002/ana.24777&rft_dat=%3Ccrossref%3E10_1002_ana_24777%3C/crossref%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c747-a552b68a70b46a8ff43a70fb30ce4aec0ab96769cae14c4a3158363ad982beec3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true